Literature DB >> 14675593

Effect of statins on the progression of bioprosthetic aortic valve degeneration.

Francesco Antonini-Canterin1, Alfredo Zuppiroli, Bogdan A Popescu, Gianluca Granata, Eugenio Cervesato, Rita Piazza, Daniela Pavan, Gian Luigi Nicolosi.   

Abstract

To date, there is no proved medical therapy able to significantly reduce the degenerative process of biologic prosthetic aortic valves. It has recently been suggested that statins may reduce the progression of native aortic valve stenosis. We examined the effect of statin treatment on bioprosthetic aortic valve degeneration and found a beneficial effect of statins in slowing bioprosthetic degeneration.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14675593     DOI： 10.1016/j.amjcard.2003.08.066

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  14 in total

1.  Differing relationship between hypercholesterolemia and a bicuspid aortic valve according to the presence of aortic valve stenosis or aortic valve regurgitation.

Authors:  Masahiro Endo; Akihiro Nabuchi; Hiroshi Okuyama; Yasushi Muto; Susumu Hiranuma; Takuya Miyazaki; Joji Hosokawa; Yoshihisa Enjoji; Yumi Shimura; Osamu Hashimoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-06-02

Review 2.  Can statins improve outcomes after isolated cardiac valve surgery? A systematic literature review.

Authors:  Jacob Chacko; Leanne Harling; Hutan Ashrafian; Thanos Athanasiou
Journal:  Clin Cardiol       Date:  2013-05-13       Impact factor: 2.882

Review 3.  Mechanisms and Drug Therapies of Bioprosthetic Heart Valve Calcification.

Authors:  Shuyu Wen; Ying Zhou; Wai Yen Yim; Shijie Wang; Li Xu; Jiawei Shi; Weihua Qiao; Nianguo Dong
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

Review 4.  Abdominal obesity and the metabolic syndrome: a surgeon's perspective.

Authors:  Patrick Mathieu
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

Review 5.  Molecular mechanisms underlying the onset of degenerative aortic valve disease.

Authors:  Daihiko Hakuno; Naritaka Kimura; Masatoyo Yoshioka; Keiichi Fukuda
Journal:  J Mol Med (Berl)       Date:  2008-09-03       Impact factor: 4.599

6.  Efficacy of simvastatin treatment of valvular interstitial cells varies with the extracellular environment.

Authors:  Elyssa L Monzack; Xiaoxiao Gu; Kristyn S Masters
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-11-20       Impact factor: 8.311

Review 7.  The 'valvulo-metabolic' risk in calcific aortic valve disease.

Authors:  Patrick Mathieu; J P Després; P Pibarot
Journal:  Can J Cardiol       Date:  2007-10       Impact factor: 5.223

Review 8.  Medical therapy for rheumatic heart disease: is it time to be proactive rather than reactive?

Authors:  Nalini M Rajamannan; Francesco Antonini-Canterin; Luis Moura; Jose L Zamorano; Raphael A Rosenhek; Patricia Jm Best; Margaret A Lloyd; F Rocha-Goncalves; Sarat Chandra; Ottavio Alfieri; Patrizio Lancellotti; Pilar Tornos; Ragavendra R Baliga; Andrew Wang; Thomas Bashore; S Ramakrishnan; Konstantinos Spargias; Mony Shuvy; Ronen Beeri; Chaim Lotan; Jassim Al Suwaidi; Vinay Bahl; Luc A Pierard; Gerald Maurer; Gian Luigi Nicolosi; Shahbudin H Rahimtoola; K Chopra; Natesa G Pandian
Journal:  Indian Heart J       Date:  2009 Jan-Feb

9.  Bioprosthetic valve degeneration due to cholesterol deposition in a patient with normal lipid profile.

Authors:  Leslie Price; Allan Sniderman; Attila Omerglu; Kevin Lachapelle
Journal:  Can J Cardiol       Date:  2007-03-01       Impact factor: 5.223

10.  Anatomical and functional changes after aortic valve replacement with different sizes of mechanical valves.

Authors:  Gokhan Ilhan; Sahin Bozok; Berkan Ozpak; Hakan Kara; Serkan Yazman; Serdar Bayrak; Ibrahim Ozsoyler; Ali Gurbuz
Journal:  Cardiovasc J Afr       Date:  2018-07-17       Impact factor: 0.802
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.